A UK company developing technology spun out of the University of Queensland is poised for growth after being acquired by biopharmaceutical giant Sanofi for up to $1.6 billion. In the largest ever deal involving a company commercialising IP from an Australian university, Sanofi will acquire London-based biotech Vicebio to advance and commercialise UQ’s Molecular Clamp…

The post Billion-dollar deal takes UQ’s vaccine tech global appeared first on InnovationAus.com.

This post was originally published on InnovationAus.com.